| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/10/2008 | CN100417416C Medicine composition containing neohouttuynin sodium and solutol HS15 |
| 09/10/2008 | CN100417412C Liver cell growing promotor injection and its preparation method and application |
| 09/10/2008 | CN100417410C Medicine for treating gastrointestinal summer damp cold and preparing method thereof |
| 09/10/2008 | CN100417393C Compound asket fern and aspirin preparation for treating cold and its preparation process |
| 09/10/2008 | CN100417392C An effervescence tablet of cold-treating preparation and preparation method thereof |
| 09/10/2008 | CN100417383C Effervescent tablet containing cefixime and its preparing method |
| 09/09/2008 | US7424529 System using host bus adapter connection tables and server tables to generate connection topology of servers and controllers |
| 09/09/2008 | US7423181 Aminoalkoxy-functional chalcones |
| 09/09/2008 | US7423057 Dihydroorotate dehydrogenase (DHODH) inhibitors; Rheumatoid arthritis, Pneumocystis carinii, fibrosis, uveitis, rhinitis, asthma, and athropathy; 2-(Biphenyl-4-ylcarbamoyl)-cyclopent-1-enecarboxylic acid |
| 09/09/2008 | US7423049 e.g., 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine; mitogen-activated protein kinase inhibitor; antiinflammatory agent, autoimmune diseases |
| 09/09/2008 | US7423047 Arylamine substituted bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 09/09/2008 | US7423023 Enhancement of immune response using targeting molecules |
| 09/09/2008 | US7423020 Therapy for behavior disorders; quantitative analysis; measuring binding |
| 09/09/2008 | US7423016 Genetic engineering; inducting immunology response |
| 09/09/2008 | US7422846 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator |
| 09/09/2008 | US7422760 Plant-based medicament for the treatment of Hepatitis C |
| 09/09/2008 | US7422752 Mutant forms of EtxB and CtxB and their use as carriers |
| 09/09/2008 | US7422749 Isolated polypeptide, encoded by nucleic acid sequence, a vector from Staphylococcus; use for activators or inhibitors in therapy, antigen for vaccination, antibodies; antibacterial agent treating Staphylococcus infections; biodrugs |
| 09/09/2008 | US7422748 Combining antigen or in vivo generator with a surfactant or with a mixture of surfactants having an overall HLB number of between 5 and 15 and comprising: ethoxylated derivatives of ester of fatty acids and ethoxylated derivatives of oils |
| 09/09/2008 | US7422740 Capable of inhibiting the cell division cycle in a target cell; for therapy of proliferative cell disorders and intracellular pathogens |
| 09/09/2008 | US7422733 Antiinflammatory agents; anticancer agents; antidiabetic agents |
| 09/09/2008 | CA2546625C Glycopeptide antibiotic derivatives |
| 09/09/2008 | CA2332389C Liposomal preparations for the application of antiseptic agents to the interior of the body |
| 09/09/2008 | CA2323086C Regulation of endogenous gene expression in cells using zinc finger proteins |
| 09/09/2008 | CA2181689C Guanylhydrazones for treating inflammatory conditions |
| 09/09/2008 | CA2171369C The use of virulence factors of pathogens to improve liposomal delivery of antibiotics and/or vaccines |
| 09/09/2008 | CA2144855C Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 09/09/2008 | CA2133644C Process for making vancomycin |
| 09/09/2008 | CA2124677C Immunopotentiatory agents and physiologically acceptable salts thereof |
| 09/04/2008 | WO2008106226A2 Macrolide compounds and methods of making and using the same |
| 09/04/2008 | WO2008106224A1 Macrolide compounds and methods of making and using the same |
| 09/04/2008 | WO2008106139A1 Inhibitors of serine proteases for the treatment of hcv infections |
| 09/04/2008 | WO2008106130A2 Tertiary amine substituted peptides useful as inhibitors of hcv replication |
| 09/04/2008 | WO2008106074A2 Methods of treating infection |
| 09/04/2008 | WO2008105826A2 Compositions compromising lysostaphin variants and methods of using the same |
| 09/04/2008 | WO2008105526A1 Macrocyclic compound |
| 09/04/2008 | WO2008105516A1 Antifungal substance |
| 09/04/2008 | WO2008105515A1 Novel hydroxamic acid derivative |
| 09/04/2008 | WO2008105113A1 Oral disinfectant, food additive comprising the disinfectant |
| 09/04/2008 | WO2008105038A1 Adhesive patch for mycosis |
| 09/04/2008 | WO2008104756A1 Urea derivatives and their therapeutic use |
| 09/04/2008 | WO2008104200A1 Use of apyrase for the treatment of a pathology resulting from endotoxin activity |
| 09/04/2008 | WO2008104199A1 Use of ecto-phosphatases for the treatment of (acute) myocardial infarction |
| 09/04/2008 | WO2008104124A1 Screening method of combination pharmaceuticals, pharmaceuticals obtained by the method and uses thereof |
| 09/04/2008 | WO2008104077A1 Small molecule inhibitors of protein arginine methyltransferases (prmts) |
| 09/04/2008 | WO2008104076A1 Electrocolloidal silver and echinacea root antimicrobial formulation |
| 09/04/2008 | WO2008080965A3 Hiv inhibiting 5,6-substituted pyrimidines |
| 09/04/2008 | WO2008077229A8 Growth inhibition of microorganisms by lactic acid bacteria |
| 09/04/2008 | WO2007099302A8 Methods of maintaining oral health in animals using morpholine derivatives |
| 09/04/2008 | US20080214802 Treating sepsis, septicemia and septic shock |
| 09/04/2008 | US20080214785 Heterodimeric receptor complex which antagonizes IL-10-related T cell-derived inducible factor for use in diagnosis, treatment and prevention of spleen associated cell proliferative disorders |
| 09/04/2008 | US20080214665 Novel Approach to Anti-Microbial Host Defense with Molecular Shields with Lipoxin Compounds |
| 09/04/2008 | US20080214648 Hiv Prodrugs Cleavable by Cd26 |
| 09/04/2008 | US20080214635 Modulation of pathogenicity |
| 09/04/2008 | US20080214623 N-(2,2-Dimethylpropyl)-6-{3-fluoro-5-[(3-isoxazolylamino)carbonyl]-2-methylphenyl}-3-pyridinecarboxamide; inhibitors of p38 kinase |
| 09/04/2008 | US20080214620 Novel inhibitors of glutaminyl cyclase |
| 09/04/2008 | US20080214591 N-Aryl Diazaspirocyclic Compounds and Methods of Preparation and Use Thereof |
| 09/04/2008 | US20080214590 Administrating a first cytidine analogue reverse transcriptase inhibitor concurrently with deoxycytidine; increasing the antiretroviral activity of the first analogue; HIV treatment |
| 09/04/2008 | US20080214588 replication inhibitors; show improved ability to inhibit the replication of mutant strains, in particular strains which show double or multiple mutations in the viral genome encoding for reverse transcriptase |
| 09/04/2008 | US20080214575 Piperidine derivatives useful as ccr5 antagonists |
| 09/04/2008 | US20080214568 Potentiation; overcoming drug resistance of such as candida albicans and/or aspergillus niger strains; kits |
| 09/04/2008 | US20080214565 Oxazolidinone Derivatives as Antimicrobials |
| 09/04/2008 | US20080214562 Chemical Compounds |
| 09/04/2008 | US20080214546 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 09/04/2008 | US20080214534 (1,10B-Dihydro-2-(Aminoalkyl-Phenyl)-5H-Pyrazolo[1,5-C][1,3]Benzoxazin-5-Yl)Phenyl Methanone Derivatives as Hiv Viral Replication Inhibitors |
| 09/04/2008 | US20080214530 Photo-Activated Disinfection |
| 09/04/2008 | US20080214529 Such as n-{3-[1-(3,3-dimethyl-butyl)-4-hydroxy-2-oxo-1,2,4a,5,6,7-hexahydro-pyrrolo[1,2-b]pyridazin-3-yl]-1,1-dioxo-1,4-dihydro-1 lambda-6-benzo[1,2,4]thiadiazin-7-yl}-methane sulfonamide; hepatitis C viral infections; inhibiting replication |
| 09/04/2008 | US20080214528 e.g. N-[3-{1-[(cyclobutyl)amino]-4-hydroxy-2-oxo-1,2-dihydro-quinolin -3-yl}-1,1-dioxo-1,4-dihydro-1 lambda 6-thieno[2,3-e][1,2,4]thiadiazin-7-yl)methyl]methane-sulfonamide; viricides for infections caused by an RNA-containing virus; hepatitis C virus (HCV) polymerase inhibitor; liver cirrhosis |
| 09/04/2008 | US20080214527 Hiv Integrase Inhibitors |
| 09/04/2008 | US20080214522 Macrocyclic indole compounds, e.g., (7R)-14-cyclohexyl-21,24-dimethyl-7,8-dihydro-6H-7,11-(epiminoethanoiminopropanothio iminomethano)indolo[1,2-e][1,5]benzoxazocin-15-one 17,17-dioxide; hepatitis C virus polymerase inhibitors |
| 09/04/2008 | US20080214518 Potentiation; overcoming drug resistance of such as klebsiella pneumoniae; kits |
| 09/04/2008 | US20080214516 Methods and compositions for inhibiting tumor growth |
| 09/04/2008 | US20080214513 Method of treating middle ear infections |
| 09/04/2008 | US20080214503 Diethyl[2-({[7-[(4-fluorophenyl)methyl]-4-hydroxy-3-({[2-(methyloxy)ethyl]amino}carbonyl)-2-oxo-1,5-naphthyridin-1(2H)-yl]acetyl}amino)ethyl]phosphonate; alone or with a second enzyme inhibitor |
| 09/04/2008 | US20080214481 Methods of Treatment of Endobronchial Infections |
| 09/04/2008 | US20080214471 Method for inhibition of viral infection |
| 09/04/2008 | US20080214447 For treatment of hepatitis C |
| 09/04/2008 | US20080214442 Fucose-containing glycoprotein; kits |
| 09/04/2008 | US20080214437 RNA interference; gene therapy; inhalers |
| 09/04/2008 | US20080214435 Leukaemia, lymphoma and myeloma; kits |
| 09/04/2008 | US20080213861 Using targeted gene expression inhibition to treat and prevent viral infection |
| 09/04/2008 | US20080213430 nucleic acid constructs, vectors, and host cells; detergents; transgenic plants; animal feeds |
| 09/04/2008 | US20080213410 Anti-human papillomas virus topical composition |
| 09/04/2008 | US20080213408 Insect Repellent |
| 09/04/2008 | US20080213398 Modified Azole Compounds as Antifungal and Antibacterial Agents |
| 09/04/2008 | US20080213391 Substance for the Treatment of Infections |
| 09/04/2008 | US20080213347 Novel ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof |
| 09/04/2008 | US20080213342 Safely controlling harmful rumen bacteria; cattle, poultry, horses, pigs, zoo animals |
| 09/04/2008 | US20080213317 Genetic engineered mutant against Escherichia; veterinary medicine |
| 09/04/2008 | US20080213310 Use of lytic toxins and toxin conjugates |
| 09/04/2008 | US20080213308 Imidazoquinoline Compounds |
| 09/04/2008 | US20080213306 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines |
| 09/04/2008 | US20080213304 Immunogenic composition or vaccine of enteric reovirus strains; avian reovirus in a live, attenuated or killed form; veterinary medicine; twisted neck, tremors; poultry, fowl |
| 09/04/2008 | US20080213299 Silver-Ionized Plant Extraction Liquid and Use Thereof |
| 09/04/2008 | US20080213297 Method of producing conjugate vaccines |
| 09/04/2008 | US20080213294 Immunization of dairy cattle with GapC protein against streptococcus infection |
| 09/04/2008 | US20080213292 Soluble And Stabilized Trimeric Form Of Gp41 Polypeptides |
| 09/04/2008 | US20080213287 Method of inhibiting infection by HCV, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell |
| 09/04/2008 | US20080213285 Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof |
| 09/04/2008 | US20080213242 Using lysozme as viracidal agent in treatment and prevention of cell proliferative diseases |